ARCHIVES

Cyclamate Review Committee Starts Survey; Inventor Castigates NCI

This article is from The Cancer Letter archive.

Vol. 01 No. 37 | September 12, 1975

Download PDF Visit The Full Archive

Related Articles

NCI Advisors Criticize Plan To Fund R01s On ESA Research With Amgen, J&J Money.

June 27, 2008

Advisors Recommend Listing Estrogen As Carcinogen.

January 12, 2001

Cancer Genome Atlas Researchers Link Cell Metabolism Pathways To Disease Aggressiveness

July 26, 2013

Congressional News: Senate Subcommittee Recommends $2.3 Bil. Budget for NCI

September 13, 1996

Hormonal Therapy Improves Prostate Cancer Survival

August 27, 2004

Final Issue of 1980

December 19, 1980